XML 68 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Share-Based Compensation
12 Months Ended
Dec. 31, 2019
Share-Based Compensation  
Share-Based Compensation

16. Share-Based Compensation Plans

Incentive Plans

Prior to June 2017, the Company made grants of restricted stock and stock options under its 2008 Equity Incentive Plan (the “2008 Plan”). In January 2017, the Board of Directors of the Company approved, and at the Company’s 2017 annual meeting of stockholders held on June 14, 2017, the Company’s stockholders adopted a 2017 Equity Incentive Plan (the “2017 Plan”) under which a maximum of 3,000 shares may be granted. As of December 31, 2019, 1,763 shares were available for grants under the 2017 Plan. All grants of equity incentives made after June 2017 have been made from the 2017 Plan.

Restricted Stock

During fiscal years 2019, 2018, and 2017, the Company granted 149, 160, and 188 shares of common stock, respectively, with a service vesting condition to certain of its executives, officers, and employees. The restricted shares have voting rights and vest evenly at 20% over each of the next five years. Upon vesting, shares will be held in lieu of taxes equivalent to the statutory tax withholding required to be paid when the restricted stock vests. During the years ended December 31, 2019, 2018 and 2017, the Company withheld 68, 151, and 151 shares of common stock in lieu of taxes at a cost of $8,127, $15,152, and $9,790, on the restricted stock vesting dates, respectively. During 2019, 2018 and 2017, following the annual stockholders meeting, the Company granted 3, 3 and 4 shares of common stock to the non-employee members of the Company’s Board of Directors. The restricted shares granted to these directors have voting rights and vest on the earlier of (a) the one year anniversary of the date of grant or (b) immediately prior to the following year’s annual stockholders’ meeting. Included in the 2019 amount are shares of common stock granted in August 2019 to two new non-employee members of the Company’s Board of Directors. The restricted shares granted to these directors have voting rights and vest on the one year anniversary of the date of grant.

In conjunction with the GCU Transaction, the Compensation Committee of the Company’s Board of Directors decided to modify the vesting condition for certain restricted stock awards for approximately 100 Transferred Employees who transferred employment from GCE to GCU, with the acceleration being contingent upon the closing of the Transaction on July 1, 2018. Refer to Note 2 for further discussion on the Transaction. As a result, the incremental share-based compensation expense from the modification on 82 restricted stock awards for the accelerated vesting date was $7,880 and is included in the university related expenses in the consolidated income statement. Additionally, the Company transferred cash to GCU totaling $9,568 to fund a deferred compensation plan in an amount equal to the value of the 86 shares forfeited by the Transferred Employees at the closing of the Transaction. This amount is included in the loss on transaction in the consolidated income statement.

A summary of the activity related to restricted stock granted under the Company’s Incentive Plan is as follows:

    

    

Weighted Average

Total

Grant Date

Shares

Fair Value per Share

Outstanding as of December 31, 2016

 

993

$

38.32

Granted

 

192

$

70.44

Vested

 

(375)

$

32.46

Forfeited, canceled or expired

 

(34)

$

44.51

Outstanding as of December 31, 2017

 

776

$

49.16

Granted

 

163

$

92.34

Vested

 

(384)

$

65.57

Forfeited, canceled or expired

 

(95)

$

71.60

Outstanding as of December 31, 2018

 

460

$

63.28

Granted

 

152

$

93.62

Vested

 

(174)

$

56.14

Forfeited, canceled or expired

 

(16)

$

82.11

Outstanding as of December 31, 2019

 

422

$

76.43

As of December 31, 2019, there was approximately $23,044 of total unrecognized share-based compensation cost related to unvested restricted stock awards. These costs are expected to be recognized over a weighted average period of 2.1 years.

Stock Options

No options were granted in 2019, 2018 and 2017. Prior to 2012, the Company granted time vested options to purchase shares of common stock with an exercise price equal to the fair market value on the date of grant to employees.

These time vested options vest ratably over a period of five years and expire ten years from the date of grant. A summary of the activity related to stock options granted under the Company’s Incentive Plan is as follows:

Summary of Stock Options Outstanding

    

    

Weighted

    

Weighted

    

Average

Average

Exercise

Remaining

Aggregate

Total

Price per

Contractual

Intrinsic

Shares

Share

Term (Years)

Value ($)(1)

Outstanding as of December 31, 2016

 

1,272

$

15.26

Granted

 

$

 

  

 

  

Exercised

 

(576)

$

12.79

 

  

 

  

Forfeited, canceled or expired

 

(2)

$

16.35

 

  

 

  

Outstanding as of December 31, 2017

 

694

$

17.31

Granted

 

$

 

  

 

  

Exercised

 

(250)

$

18.47

 

  

 

  

Forfeited, canceled or expired

 

$

 

  

 

  

Outstanding as of December 31, 2018

 

444

$

16.66

Granted

 

$

 

  

 

  

Exercised

 

(212)

$

18.01

 

  

 

  

Forfeited, canceled or expired

 

$

 

  

 

  

Outstanding as of December 31, 2019

 

232

$

15.42

 

1.18

$

18,568

Exercisable as of December 31, 2019

 

232

$

15.42

 

1.18

$

18,568

(1)Aggregate intrinsic value represents the value of the Company’s closing stock price on December 31, 2019 ($95.79) in excess of the exercise price multiplied by the number of options outstanding or exercisable.

Share-based Compensation

Share-based Compensation Expense Assumptions – Restricted Stock Awards

The Company measures and recognizes compensation expense for share-based payment awards made to employees and directors. The fair value of the Company’s restricted stock awards is based on the market price of its common stock on the date of grant. Stock-based compensation expense related to restricted stock grants is expensed over the vesting period using the straight-line method for Company employees and the Company’s board of directors. Starting January 1, 2017 with the adoption of the share-based compensation accounting standard, the Company made an accounting policy election to account for forfeitures as they occur, prior to 2017 these forfeitures were estimated and reported net of the expense. The restricted shares have voting rights.

The table below outlines share-based compensation expense for the fiscal years ended December 31, 2019, 2018 and 2017 related to restricted stock and stock options granted:

    

2019

    

2018

    

2017

Technology and academic services

$

1,721

$

1,585

$

1,555

Counseling support and services

 

5,297

 

4,926

 

4,700

Marketing and communication

 

87

 

48

 

26

General and administrative

 

3,195

 

3,355

 

3,402

University related expenses

 

 

9,594

 

3,005

Share-based compensation expense included in operating expenses

 

10,300

 

19,508

 

12,688

Tax effect of share-based compensation

 

(2,575)

 

(4,877)

 

(5,075)

Share-based compensation expense, net of tax

$

7,725

$

14,631

$

7,613

401(k) Plan

The Company has established a 401(k) Defined Contribution Benefit Plan (the “Plan”). The Plan provides eligible employees, upon date of hire, with an opportunity to make tax-deferred contributions into a long-term investment and savings program. All employees over the age of 21 are eligible to participate in the plan. The Plan allows eligible employees to contribute to the Plan subject to Internal Revenue Code restrictions and the Plan allows the Company to make discretionary matching contributions. The Company plans to make a matching contribution to the Plan of approximately $2,238 for the year ended December 31, 2019. The Company made discretionary matching contributions to the Plan of $1,625 and $2,837 for the years ended December 31, 2018 and 2017, respectively.